Drug Profile
Research programme: schizophrenia therapies - deCODE genetics
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator deCODE genetics
- Class Small molecules
- Mechanism of Action ERBB 4 receptor agonists; NMDA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Schizophrenia in Europe
- 26 Jul 2007 Preclinical development is ongoing
- 23 Aug 2005 This programme is still in active development